Putting an EMPHASYS on What Matters Most

Patients and their surgeons; we think about them every day. Why? Because they’re who matter most to us at DePuy Synthes. How can we improve the standard of care? And how can we help surgeons and their teams deliver that care accurately and reliably every single time? These are the questions we emphasize as we make decisions, because a company—with our legacy—is committed to meeting the needs of patients and their surgeons.?

For hip replacements, we focus on three ingredients that we know to be the keys to success in the operating room (OR) and beyond—the implant, the surgical technique, and the enabling technologies. We know that by empowering orthopaedic surgeons with differentiated implants, techniques and technologies, we aim to deliver accuracy, reproducibility and improved patient outcomes in hip reconstruction surgeries, helping to create operating room efficiencies.

This matters now more than ever. We know that the patient population for hip reconstruction is growing[1], which increases the need for surgeons to address a broad array of anatomical needs. Many of these patients are younger and they bring with them higher expectations than patients of years past.[2] Add to that, many patients whose treatment was deferred during the pandemic are now ready for their hip reconstruction surgeries.[3]

But are healthcare facilities ready for them? This is where efficiency comes in. As healthcare facilities emerge from COVID-19, administrators are faced with the challenge of maximizing resources to prepare for what is projected to be a doubling of volume for total hip reconstruction surgeries over the next 8 years.[4] Plus, many patients are looking to receive care in an out-patient setting, such as an Ambulatory Surgical Center (ASC)—a trend that is expected to continue growing.[5] In an ASC, managing volume with efficiency is key to minimizing the burdens on surgeons and their teams.

EMPHASY-ZING Relief

This is a unique moment in time and we’re poised and ready to help because that’s what we do. We offer innovations that aim to meet the needs of today’s surgeons and today’s patients.

To that end, we are excited to announce the launch of our latest innovation; EMPHASYS? Femoral Solutions, building on the success of the CORAIL? Hip System[6] and DePuy Synthes’ ongoing commitment to empowering orthopaedic surgeons with differentiated implants, techniques and technologies.

With EMPHASYS Femoral Solutions, we are helping surgeons and their patients, in three important ways:

• Addressing diverse global patient needs: We are supporting surgeons with better fitting implants (of differing sizes and options) so that they can provide care for a broad global population.[7],[8]
• Improving patient outcomes: We are focusing on bone preservation to enhance stability to deliver improved patient outcomes.[9],[10]
• Minimizing staff burden: For the surgical team, managing growing patient demand, we are helping to create an efficient workflow with fewer instruments in the OR.[11],[12],[13]

Our Value Proposition

We are especially excited about EMPHASYS Femoral Solutions because the incredible value it can add to our existing techniques and technology.

• With ANTERIOR ADVANTAGE? Hip Solutions, patients may recover faster, have shorter hospital stays, experience less pain and use fewer pain relievers when compared to other approaches.[14],[15],[16]
• When used with the ACTIS? Hip System, the KINCISE? Surgical Automated System has been shown to reduce the time the patients spend in the OR. Using the KINCISE System ?may reduce the fatigue surgeons experience during total hip arthroplasty.[17]
• By using our enabling technology like VELYS? Hip Navigation, surgeons may not only benefit from the efficiencies that EMPHASYS offers, but also from actionable, real-time data that leads to precision in implant placement, while optimizing processes and procedures in the OR.[18]

It is time for the medical technology industry to step up and meet the next wave of patient and surgeon demand. I’m proud that EMPHASYS Femoral Solutions will help to lead that charge.

Please refer to the instructions for use for a complete list of indications, contraindications, warnings and precautions.

214375-220520 DSUS

? DePuy Synthes 2022. All rights reserved.

####

[1] Singh JA, Yu S, Chen L, Cleveland JD (2019) Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. The Journal of Rheumatology 46 (9): 1134-1140.

[2] Bayliss LE, Culliford D, Monk AP, et al. The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet (London, England). 2017;389(10077):1424-1430. doi:10.1016/S0140-6736(17)30059-4

[3] Brown et al. The Effect of the COVID-19 Pandemic on Electively Scheduled Hip and Knee Arthroplasty Patients in the United States. J Arthroplasty. 2020 Jul;35(7S):S49-S55.

[4] Singh JA, Yu S, Chen L, Cleveland JD (2019) Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. The Journal of Rheumatology 46 (9): 1134-1140.

[5] Bert JM, Hooper J, Moen S (2017) Outpatient total joint arthroplasty. Current Reviews in Musculoskeletal Medicine 10 (4): 567-574.

[6] Jacquot L, Bonnin MP, Machenaud A, Chouteau J, Saffarini M, Vidalain JP. Clinical and Radiographic Outcomes at 25-30 Years of a Hip Stem Fully Coated With Hydroxylapatite. J Arthroplasty. 2018 Feb;33(2):482-490

[7] DePuy Synthes “SEA EMPHASYS Femoral Claims Matrix Supporting Summary”. 2021. Adaptiv 103876234

[8] DePuy Synthes “Appendix 1 Anatomic Variation”. 2021. Adaptiv 103876234

[9] DePuy Synthes “SEA EMPHASYS Femoral Claims Matrix Supporting Summary”. 2021. Adaptiv 103876234

[10] DePuy Synthes “Attachment 3 SEA Final Surgeon Validation Confirmation Presentation”. 2021. Adaptiv 103820941

[11] DePuy Synthes “SEA EMPHASYS Femoral Claims Matrix Supporting Summary”. 2021. Adaptiv 103876234

[12] DePuy Synthes “Appendix 1 Anatomic Variation”. 2021. Adaptiv 103876234

[13] DePuy Synthes “SEA EMPHASYS Biomechanical Restoration Range Assessment”. 2021. Adaptiv 103810746

[14] Miller LE et al. Does Surgical Approach Affect Outcomes in Total Hip Arthroplasty Through 90 Days Follow-up? A Systematic Review with Meta-analysis. The Journal of arthroplasty. 2017 Nov 14.

[15] Zawadsky MW, et al. “Early Outcome Comparison Between the Direct Anterior Approach and the Mini-Incision Posterior Approach for Primary Total Hip Arthroplasty: 150 Consecutive Cases.” The Journal of Arthroplasty 2014; (29): 1256-1260. (Ant Adv)

[16] Schweppe et al. Does Surgical Approach in Total Hip Arthroplasty Affect Rehabilitation, Discharge Disposition, and Readmission Rate? Surgical Technology International XXIII. 2013. Orthopedic Surgery, 219-227. (Ant Adv)

[17] Ferrari E, Khan M, Mantel J, Wallbank R. The assessment of muscle fatigue in orthopedic surgeons, by comparing manual versus automated broaching in simulated total hip arthroplasty. Proc Inst Mech Eng H. 2021 Dec;235(12):1471-1478

[18] Goodell PB et al Presented at AAHKS, Dallas Nov 7-10th 2019.